Last10K.com

Bluebird Bio, Inc. (BLUE) SEC Filing 8-K Material Event for the period ending Tuesday, November 29, 2022

Bluebird Bio, Inc.

HISTORY TOOLS
CIK: 1293971 Ticker: BLUE

View differences made from one to another to evaluate Bluebird Bio, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bluebird Bio, Inc..

Continue

Assess how Bluebird Bio, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bluebird Bio, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information

Material Contracts, Statements, Certifications & more

Bluebird Bio, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 2.1: Plan Of Acquisition, Reorganization, Arrangement, Liquidation Or Succession
Ticker: BLUE
CIK: 1293971
Form Type: 8-K Corporate News
Accession Number: 0001193125-22-294908
Submitted to the SEC: Wed Nov 30 2022 7:13:01 AM EST
Accepted by the SEC: Wed Nov 30 2022
Period: Tuesday, November 29, 2022
Industry: Biological Products No Disgnostic Substances
Events:
  1. Financial Exhibit
  2. New Agreement

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/blue/0001193125-22-294908.htm